Skip to main content
Clinical Trials/NCT03218735
NCT03218735
Withdrawn
Not Applicable

Early Term Delivery Versus Expectant Management of the Large for Gestational Age Fetus (TEAM LGA Trial)

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Macrosomia, Fetal
Sponsor
The University of Texas Health Science Center, Houston
Primary Endpoint
Number of children with birthweight above 4500 grams
Status
Withdrawn
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to compare the incidence of composite neonatal morbidity and birthweight >4500 grams among uncomplicated large for gestational age (LGA) fetal growth at delivered 37 weeks versus expectant management.

Registry
clinicaltrials.gov
Start Date
July 12, 2017
End Date
August 1, 2019
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Bahaeddine M Sibai

Professor

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • Singleton pregnancy
  • Plan for vaginal delivery. Patients with prior cesarean section are eligible if they are planning for a trial of labor after cesarean section.
  • Gestational age 34 weeks 0 days to 37 weeks 0 days at time of enrollment
  • Dating of pregnancy by last menstrual period consistent with an ultrasound, ultrasound \<21 weeks and 6 days of gestation, or known date of conception in the setting of in vitro fertilization
  • No known major anomalies (anomalies requiring surgery antenatally or in the neonatal period, anomalies not compatible with life as determined by the physician)
  • LGA defined as estimated fetal weight (EFW) \> 90th percentile by Hadlock formula but \<4500 grams

Exclusion Criteria

  • Pre-gestational diabetes or gestational diabetes on medication (oral or insulin, excluding metformin)
  • Planned cesarean delivery
  • Polyhydramnios
  • Known major fetal anomalies
  • Multiple gestation or selective reduction of multiple gestation after 14 weeks
  • Previous stillbirth at term
  • Indications for delivery at \<39 weeks. Common examples include:
  • Placenta previa
  • Placenta accreta
  • Vasa previa

Outcomes

Primary Outcomes

Number of children with birthweight above 4500 grams

Time Frame: Immediately at birth

Number of children presenting with CNM

Time Frame: Up to 6 weeks after delivery

Composite neonatal morbidity (CNM) is any of the following: Apgar score \<5 at 5 minutes, seizure, fracture of skull, humerus, or clavicle, neonatal brachial plexus palsy, facial nerve palsy, oxygen supplementation \>4 hours, CPAP \>2 hours, mechanical ventilation, or death before discharge or IUFD.

Secondary Outcomes

  • Number of children delivered by cesarean section(Immediately at birth)
  • Number of children admitted to NICU(Up to 6 weeks after delivery)
  • Number of women presenting with CMM(Up to 6 weeks after delivery)

Similar Trials